The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-fluorobenzyloxy)benzaldehyde O-1-methylpiperidin-3-yl oxime ID: ALA2333253
PubChem CID: 71653714
Max Phase: Preclinical
Molecular Formula: C20H23FN2O2
Molecular Weight: 342.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCCC(O/N=C/c2ccccc2OCc2cccc(F)c2)C1
Standard InChI: InChI=1S/C20H23FN2O2/c1-23-11-5-9-19(14-23)25-22-13-17-7-2-3-10-20(17)24-15-16-6-4-8-18(21)12-16/h2-4,6-8,10,12-13,19H,5,9,11,14-15H2,1H3/b22-13+
Standard InChI Key: RYJIDEOXCRQAFX-LPYMAVHISA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
30.8272 -21.6137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5345 -21.2044 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2426 -21.6122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9499 -21.2029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6580 -21.6108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6537 -22.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3610 -22.8331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0692 -22.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0658 -21.6023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3579 -21.1982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1212 -21.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4160 -21.6146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4127 -22.4321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1206 -22.8421 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8320 -22.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1187 -23.6593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9450 -22.8323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.9431 -23.6495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6498 -24.0597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6446 -24.8759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3505 -25.2861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0602 -24.8791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0595 -24.0577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3530 -23.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7667 -23.6483 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 11 1 0
1 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 1 0
6 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
23 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.41Molecular Weight (Monoisotopic): 342.1744AlogP: 3.85#Rotatable Bonds: 6Polar Surface Area: 34.06Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.79CX LogP: 4.27CX LogD: 3.73Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.59Np Likeness Score: -1.13
References 1. Kim YS, Jung SH, Park BG, Ko MK, Jang HS, Choi K, Baik JH, Lee J, Lee JK, Pae AN, Cho YS, Min SJ.. (2013) Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction., 62 [PMID:23353734 ] [10.1016/j.ejmech.2012.12.033 ]